"Cell Transplantation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transference of cells within an individual, between individuals of the same species, or between individuals of different species.
| Descriptor ID |
D017690
|
| MeSH Number(s) |
E02.095.147.500 E04.936.225
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cell Transplantation".
Below are MeSH descriptors whose meaning is more specific than "Cell Transplantation".
This graph shows the total number of publications written about "Cell Transplantation" by people in this website by year, and whether "Cell Transplantation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 1 | 2 |
| 2005 | 1 | 1 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 3 | 0 | 3 |
| 2014 | 2 | 0 | 2 |
| 2016 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Transplantation" by people in Profiles.
-
Lee B, Parvizi J, Bramlet D, Romness DW, Guermazi A, Noh M, Sodhi N, Khlopas A, Mont MA. Results of a Phase II Study to Determine the Efficacy and Safety of Genetically Engineered Allogeneic Human Chondrocytes Expressing TGF-?1. J Knee Surg. 2020 Feb; 33(2):167-172.
-
Charsar BA, Urban MW, Lepore AC. Harnessing the power of cell transplantation to target respiratory dysfunction following spinal cord injury. Exp Neurol. 2017 Jan; 287(Pt 2):268-275.
-
Cherian JJ, Parvizi J, Bramlet D, Lee KH, Romness DW, Mont MA. Preliminary results of a phase II randomized study to determine the efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-?1 in patients with grade 3 chronic degenerative joint disease of the knee. Osteoarthritis Cartilage. 2015 Dec; 23(12):2109-2118.
-
Petrof G, Abdul-Wahab A, McGrath JA. Cell therapy in dermatology. Cold Spring Harb Perspect Med. 2014 Jun 02; 4(6).
-
Ghosh B, Zhang C, Smith GM. Bridging between transplantation therapy and neurotrophic factors in Parkinson's disease. Front Biosci (Elite Ed). 2014 Jun 01; 6:225-35.
-
Shukla V, Ma S, Hardy RR, Joshi SS, Lu R. A role for IRF4 in the development of CLL. Blood. 2013 Oct 17; 122(16):2848-55.
-
Uitto J. Cell-based therapy for RDEB: how does it work? J Invest Dermatol. 2011 Aug; 131(8):1597-9.
-
Frisbie DD, Stewart MC. Cell-based therapies for equine joint disease. Vet Clin North Am Equine Pract. 2011 Aug; 27(2):335-49.
-
Li SC, Jin Y, Loudon WG, Song Y, Ma Z, Weiner LP, Zhong JF. Increase developmental plasticity of human keratinocytes with gene suppression. Proc Natl Acad Sci U S A. 2011 Aug 02; 108(31):12793-8.
-
Nagy N, Almaani N, Tanaka A, Lai-Cheong JE, Techanukul T, Mellerio JE, McGrath JA. HB-EGF induces COL7A1 expression in keratinocytes and fibroblasts: possible mechanism underlying allogeneic fibroblast therapy in recessive dystrophic epidermolysis Bullosa. J Invest Dermatol. 2011 Aug; 131(8):1771-4.